title: Case for sleeve gastrectomy.
abstract: During the last 10 years, laparoscopic sleeve gastrectomy (LSG) has progressively increased in popularity as a primary procedure because of its simplicity, safety, and effectiveness to achieve sustained weight loss over time. The efficacy of LSG in the metabolic control of type 2 diabetes (T2D) is the result of various mechanisms not thoroughly elucidated. Thus, excellent short-term outcomes have been published in glycemic control after SG at comparable rates to Roux-en-Y gastric bypass (RYGB). Unfortunately, head-to-head comparative studies between SG and RYGB are limited and long-term follow-up data is not abundant. The aim of this manuscript is to describe current evidence on the clinical impact of SG on T2D as well as to provide a critical appraisal of the available published data.
authors: Division of Gastrointestinal Surgery, Institute of Metabolic and Digestive Diseases, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
authors: Ricard
authors: R
authors: Corcelles
authors: Division of Gastrointestinal Surgery, Institute of Metabolic and Digestive Diseases, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain; Gastrointestinal Surgery Division, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain. Electronic address: alacy@medicina.ub.es.
authors: Antonio
authors: A
authors: Lacy
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000601:surgery*; D005743:Gastrectomy / Q000379:methods*; D006801:Humans; D010535:Laparoscopy / Q000379:methods*; D009767:Obesity, Morbid / Q000601:surgery; D064887:Observational Studies as Topic; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
keywords: Sleeve gastrectomy